Superior Planning, LLC’s Vera Therapeutics VERA Stock Holding History

Superior Planning, LLC’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$452	Buy	+14	New	+$490	﹤0.01%	1918

Other funds holding VERA

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Davern Capital Partners Ny, New York $514M AUM 16.9% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Superior Planning, LLC's VERA Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Vera Therapeutics (VERA) in Q3 2026: 14 shares worth $452. The stake represents ﹤0.01% of the portfolio and ranks #1918 among its holdings.

111 funds tracked by Wall St. Rank hold VERA as of Q3 2026.

Superior Planning, LLC held 14 shares of Vera Therapeutics worth $452 as of Q3 2026.
Vera Therapeutics was a new Superior Planning, LLC position in Q3 2026.
Vera Therapeutics made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1918 holding.
111 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.